24
Participants
Start Date
August 25, 2025
Primary Completion Date
December 25, 2025
Study Completion Date
March 25, 2026
Afatinib Dimaleat
printed capsule containing 40 mg afatinib dimaleate
inhalation of afatinib dimaleate
inhalation stable form of afatinib dimaleate at an equivalent therapeutic dose in a single-use maintenance-free ultrasonic inhaler with controlled frequency and number of inhalations
Central Contact, Auckland
Petrov, Andrey
OTHER